ALPA LABORATORIES
|
ALPA LABORATORIES Last 5 Year Financial Ratios History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 9.27 | 7.97 | 5.98 | 6.70 | 3.44 |
| CEPS(Rs) | 10.32 | 8.90 | 6.61 | 7.48 | 4.03 |
| DPS(Rs) | - | - | - | - | - |
| Book NAV/Share(Rs) | 81.48 | 72.20 | 63.96 | 57.86 | 51.16 |
| Tax Rate(%) | 24.01 | 18.88 | 20.81 | 27.96 | 32.81 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 4.23 | 7.45 | 8.69 | 9.50 | 7.89 |
| EBIT Margin(%) | 23.03 | 19.35 | 17.34 | 17.62 | 11.14 |
| Pre Tax Margin(%) | 22.82 | 19.02 | 17.09 | 17.42 | 11.06 |
| PAT Margin (%) | 17.34 | 15.43 | 13.54 | 12.55 | 7.43 |
| Cash Profit Margin (%) | 19.30 | 17.23 | 14.97 | 14.03 | 8.69 |
| Performance Ratios | |||||
| ROA(%) | 9.63 | 9.60 | 7.80 | 9.53 | 5.56 |
| ROE(%) | 12.06 | 11.71 | 9.82 | 12.29 | 6.97 |
| ROCE(%) | 15.76 | 14.31 | 12.19 | 16.81 | 10.42 |
| Asset Turnover(x) | 0.56 | 0.62 | 0.58 | 0.76 | 0.75 |
| Sales/Fixed Asset(x) | 2.47 | 2.97 | 2.74 | 3.45 | 2.76 |
| Working Capital/Sales(x) | 0.77 | 0.82 | 0.78 | 1.03 | 1.10 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.40 | 0.34 | 0.37 | 0.29 | 0.36 |
| Receivable days | 142.78 | 147.50 | 166.43 | 119.43 | 112.28 |
| Inventory Days | 50.81 | 44.15 | 55.18 | 52.06 | 54.46 |
| Payable days | 79.22 | 71.98 | 99.58 | 103.71 | 117.94 |
| Valuation Parameters | |||||
| PER(x) | 11.23 | 10.46 | 8.99 | 10.38 | 10.50 |
| PCE(x) | 10.09 | 9.37 | 8.13 | 9.29 | 8.97 |
| Price/Book(x) | 1.28 | 1.16 | 0.84 | 1.20 | 0.71 |
| Yield(%) | - | - | - | - | - |
| EV/Net Sales(x) | 1.93 | 1.65 | 1.15 | 1.34 | 0.67 |
| EV/Core EBITDA(x) | 7.72 | 7.79 | 6.11 | 7.02 | 5.44 |
| EV/EBIT(x) | 8.37 | 8.51 | 6.62 | 7.61 | 6.05 |
| EV/CE(x) | 1.26 | 1.14 | 0.78 | 0.97 | 0.47 |
| M Cap / Sales | 1.95 | 1.61 | 1.22 | 1.30 | 0.78 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 3.41 | 16.98 | -17.20 | 15.08 | 13.48 |
| Core EBITDA Growth(%) | 22.20 | 31.83 | -18.63 | 77.27 | 92.93 |
| EBIT Growth(%) | 23.09 | 30.58 | -18.54 | 82.07 | 250.05 |
| PAT Growth(%) | 16.25 | 33.33 | -10.71 | 94.45 | 291.02 |
| EPS Growth(%) | 16.25 | 33.33 | -10.71 | 94.45 | 291.02 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | - | 0.03 | 0.02 | 0.05 | - |
| Current Ratio(x) | 4.12 | 5.74 | 5.03 | 4.79 | 3.73 |
| Quick Ratio(x) | 3.74 | 5.25 | 4.61 | 4.25 | 3.22 |
| Interest Cover(x) | 111.73 | 58.58 | 72.07 | 90.32 | 139.47 |
| Total Debt/Mcap(x) | - | 0.03 | 0.02 | 0.04 | - |
Compare Financial Ratios of peers of ALPA LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALPA LABORATORIES | ₹188.0 Cr | 1.6% | -5.7% | -23.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹407,791.0 Cr | 1.2% | 4.2% | -10.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹174,885.0 Cr | -0.5% | 8.9% | 10.8% | Stock Analytics | |
| CIPLA | ₹127,930.0 Cr | 0.4% | 3.7% | 8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹121,108.0 Cr | -0% | -2.1% | 6.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,164.0 Cr | 2.2% | -1.8% | -4.4% | Stock Analytics | |
ALPA LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALPA LABORATORIES | 1.6% |
-5.7% |
-23.9% |
| SENSEX | 0.9% |
2.5% |
3.7% |
You may also like the below Video Courses
